Loading clinical trials...
Loading clinical trials...
Exposure-based cognitive behavior therapy is an efficacious treatment for speech anxiety and has been delivered effectively in a virtual reality (VR) environment. The present multicenter study (conducted through the Exposure Therapy Consortium) is designed to evaluate whether trait versus state positive affectivity is a more effective predictor of exposure therapy outcomes. Further, the investigators will examine whether the predictive significance of trait positive affectivity can be accounted for by examination of baseline levels of self-efficacy, hope, and optimism.
The goal of this multicenter clinical trial is to examine predictors of VR exposure therapy outcomes for college students with public speaking anxiety following a positive or negative mood induction. The overarching aim of the present study is to evaluate whether trait versus state positive affectivity is a more effective predictor of exposure therapy outcomes. Further, the investigators will examine whether the predictive significance of trait positive affectivity can be accounted for by examination of baseline levels of self-efficacy, hope, and optimism. State affect is manipulated at an experimental level with affect induction procedures; trait positive affectivity is measured at baseline. The study involves three phases: (1) initial screening, (2) in-person assessment and brief exposure intervention for a subset of participants with elevated public speaking anxiety, and (3) a one-week follow-up assessment conducted online. Students who choose to participate and screen high on a public speaking anxiety scale will be assigned to a positive or negative mood induction condition prior to undergoing VR-based exposure therapy. Public speaking and social anxiety outcomes are measured immediately post-intervention and one week later. The one-week follow-up assessment represents the primary outcome.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
Yes
University of Arizona
Tucson, Arizona, United States
Southern Illinois University
Carbondale, Illinois, United States
Tufts University
Boston, Massachusetts, United States
Boston University
Boston, Massachusetts, United States
Albright College
Reading, Pennsylvania, United States
University of Texas at Austin
Austin, Texas, United States
Western Sydney University
Penrith, New South Wales, Australia
University of New South Wales
Sydney, New South Wales, Australia
Curtin University
Bently, Western Australia, Australia
University of Hong Kong
Pokfulam, Hong Kong, China
Start Date
October 8, 2024
Primary Completion Date
July 23, 2025
Completion Date
July 23, 2025
Last Updated
December 18, 2025
1,542
ACTUAL participants
Single-session VR exposure intervention
BEHAVIORAL
Lead Sponsor
Boston University Charles River Campus
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions